HYBRID EVENT: You can participate in person at Tokyo, Japan or Virtually from your home or work.
5th Edition of
International Vaccines Congress
October 23 -25, 2025 | Orlando, Florida, USA
Scientific Program
About
Scientific Committee Members
Khursheed Nadeem Anwer
Imunon Inc., United States
Ping Xie
Rutgers University, United States
Regina Au
BioMarketing Insight, United States
Madhu Khanna
University of Delhi, India
Gallery
Vaccine Conference 2024 | Baltimore, MD, USA
Vaccine Conference 2023 | Boston, USA
Pharma Conference 2019 | Paris, France
Pharma Conference 2018 | Rome, Italy
Pharmaceutics Conference 2017 | Valencia, Spain
Reviews
Pharma Conference 2018 | Rome, Italy
Pharma Conference 2017 | Valencia, Spain
Magnus Group Conferences Reveiws
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data for a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Nadeem Anwer, Imunon Inc., United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom